Pharma industry venture financing deals in July 2019 total $2.38bn globally
Total pharma industry venture financing deals in July 2019 worth $2.38bn were announced globally, according to GlobalData's deals database. Embed...
Focus:
-
CureVacPartnershipUndisclosed
-
Boehringer IngelheimPartnershipUndisclosed
-
Jazz PharmaceuticalsMergers & Acquisitions$312.5M
-
Sonnet BioTherapeuticsMergers & AcquisitionsUndisclosed
-
BayerMergers & Acquisitions$1BN
-
HummingbirdPartnershipUndisclosed
-
CambrexMergers & Acquisitions$2.4BN
-
Innovent BiologicsPartnershipUndisclosed
-
Sosei HeptaresPartnershipUndisclosed
-
Santhera PharmaceuticalsLicensing AgreementUndisclosed
-
Antikor BiopharmaPartnership$3.1M
-
BayerPartnershipUndisclosed
-
ACG EngineeringMergers & AcquisitionsUndisclosed
-
GlaxoSmithKlineMergers & AcquisitionsUndisclosed
-
ExelixisLicensing AgreementUndisclosed
-
Alligator BiosciencePartnershipUndisclosed
-
PfizerMergers & AcquisitionsUndisclosed
-
ZambonMergers & Acquisitions$550M
-
SanofiLicensing Agreement$47M
-
NeuroBo PharmaceuticalsMergers & AcquisitionsUndisclosed
-
CelgeneLicensing Agreement$50M
-
SanofiLicensing AgreementUndisclosed
-
Gilead SciencesLicensing AgreementUndisclosed
-
Boehringer IngelheimLicensing Agreement$1.2BN
-
MallinckrodtLicensing AgreementUndisclosed
-
Astellas PharmaLicensing AgreementUndisclosed
-
AUM BiosciencesLicensing AgreementUndisclosed
-
GenentechPartnershipUndisclosed
-
Boehringer IngelheimMergers & Acquisitions$366M
-
Recursion PharmaceuticalsCapital Raising$121M
-
![CureVac, Yale University to develop mRNA-based lung therapies]()
CureVac and Yale University to develop mRNA-based lung therapies
-
![Boehringer partners MD Anderson on virtual R&D center]()
Boehringer partners with MD Anderson on virtual R&D centre
-
![]()
Deals interview with Mike Preston of Cleary Gottlieb: Oncology is driving healthcare M&As
-
![Jazz Pharmaceuticals acquires Cavion in $312.5m deal]()
Jazz Pharmaceuticals acquires Cavion in $312.5m deal
-
![Bayer BlueRock acquire]()
Bayer agrees to acquire biotech BlueRock for $1bn
-
![]()
Hummingbird and Cancer Research UK to develop antibody drug HMBD-001
Submit a deal
Ensure your company's deals are accurately presented to thousands of potential clients by using our deals submission form.
DEALS ANALYSIS
China’s pharma industry sees a drop of 28.1% in deal activity in Q2 2019
China's pharma industry saw a drop of 28.1% in overall deal activity during Q2 2019, when compared with the last four-quarter average, according to GlobalData's deals database.
North America’s pharma industry sees a drop of 10.3% in deal activity in Q2 2019
North America's pharma industry saw a drop of 10.3% in overall deal activity during Q2 2019, when compared to the four-quarter average, according to GlobalData's deals database.
Europe’s pharma industry sees a rise of 1.2% in deal activity in Q2 2019
Europe's pharma industry saw a rise of 1.2% in overall deal activity during Q2 2019, when compared to the four-quarter average, according to GlobalData's deals database.
Pharma industry M&A deals in Q2 2019 total $114.8bn globally
Total pharma industry M&A deals in Q2 2019 worth $114.8bn were announced globally, according to GlobalData's deals database.
Pharma industry venture financing deals in Q2 2019 total $2.72bn in US
Total pharma industry venture financing deals in Q2 2019 worth $2.72bn were announced in the US, according to GlobalData's deals database.
Pharma industry deals in Q2 2019 total $121.51bn globally
Total pharma industry deals for Q2 2019 worth $121.51bn were announced globally, according to GlobalData's deals database.
Pharma industry private equity deals in Q2 2019 total $2.98bn globally
Total pharma industry private equity deals in Q2 2019 worth $2.98bn were announced globally, according to GlobalData's deals database.
Pharma industry venture financing deals in Q2 2019 total $3.72bn globally
Total pharma industry venture financing deals in Q2 2019 worth $3.72bn were announced globally, according to GlobalData's deals database.
Pharma industry M&A deals in Q2 2019 total $19.5bn in US
Total pharma industry M&A deals in Q2 2019 worth $19.5bn were announced in the US, according to GlobalData's deals database.
Pharma industry deals in June 2019 total $102.8bn globally
Total pharma industry deals for June 2019 worth $102.8bn were announced globally, according to GlobalData's deals database.
DEALS NEWS
Close
Close
Close
Go Top
